FEBS Open Bio (Jul 2017)

Antimicrobial ceragenins inhibit biofilms and affect mammalian cell viability and migration in vitro

  • Melissa A. Olekson,
  • Tao You,
  • Paul B. Savage,
  • Kai P. Leung

DOI
https://doi.org/10.1002/2211-5463.12235
Journal volume & issue
Vol. 7, no. 7
pp. 953 – 967

Abstract

Read online

The healing of burn wounds is often hampered by bacterial infection and the formation of biofilms. Antimicrobial peptides (AMPs) are effective in promoting wound healing, but are susceptible to degradation. We have tested the ability of ceragenins (CSAs), mimics of antimicrobial peptides, to mitigate preformed biofilms and stimulate wound healing in vitro. Potent CSAs (MICs 10 μg·mL−1), lower concentrations of CSA‐13 and CSA‐192 stimulated cell migration. CSA‐13, CSA‐90, and CSA‐142 also stimulated tube formation in an in vitro angiogenesis model. An inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2) blocked tube formation stimulated by CSA‐13, suggesting that CSA‐13 signals through this receptor. Ceragenins display anti‐biofilm activity and stimulate migration and tube formation in vitro. This work suggests that ceragenins have the potential to be both topical antimicrobials and wound‐healing adjunct therapeutics.

Keywords